The formation of such antibodies could theoretically increase allergy risk over time, but the published data does not indicate concerning rates of antibody development that would suggest emerging immunogenicity problems
We offer a free Discovery Call, where one of our healthcare professionals will discuss your symptoms and treatment goals and help you understand if custom, in-home treatment for chronic gastritis is right for you
Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
10.1073/pnas.96.26.14843 90 MojsovS.WeirG
